These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29562500)

  • 1. Down-regulated serum miR-126 is associated with aggressive progression and poor prognosis of gastric cancer.
    Feng R; Beeharry MK; Lu S; Sah BK; Yuan F; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 22(1):119-126. PubMed ID: 29562500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
    Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dysregulation of miR-126/Crk protein axis predicts poor prognosis in gastric cancer patients.
    Feng R; Sah BK; Beeharry MK; Yuan F; Su L; Jin X; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018 Feb; 21(2):335-343. PubMed ID: 29171987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
    Kong Y; Ning L; Qiu F; Yu Q; Cao B
    Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Implications of miR-302a/b/c/d in Human Gastric Cancer.
    Ma G; Li Q; Dai W; Yang X; Sang A
    Pathol Oncol Res; 2017 Oct; 23(4):899-905. PubMed ID: 28795345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer.
    Imaoka H; Toiyama Y; Okigami M; Yasuda H; Saigusa S; Ohi M; Tanaka K; Inoue Y; Mohri Y; Kusunoki M
    Gastric Cancer; 2016 Jul; 19(3):744-53. PubMed ID: 26233325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of tissue miR-338-3p predicts unfavorable prognosis of gastric cancer.
    Liu S; Suo J; Wang C; Sun X; Wang D; He L; Zhang Y; Li W
    Cancer Biomark; 2017 Dec; 21(1):117-122. PubMed ID: 29060930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Upregulation of microRNA-23a/b promotes tumor progression and confers poor prognosis in patients with gastric cancer.
    Ma G; Dai W; Sang A; Yang X; Gao C
    Int J Clin Exp Pathol; 2014; 7(12):8833-40. PubMed ID: 25674252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of combined microRNA-206 and CyclinD2 in gastric cancer patients after curative surgery: A retrospective cohort study.
    Shi H; Han J; Yue S; Zhang T; Zhu W; Zhang D
    Biomed Pharmacother; 2015 Apr; 71():210-5. PubMed ID: 25960238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced expression of serum miR-204 predicts poor prognosis of gastric cancer.
    Chen X; Liu XS; Liu HY; Lu YY; Li Y
    Genet Mol Res; 2016 Apr; 15(2):. PubMed ID: 27173244
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum miR-126 level combined with multi- detector computed tomography in the preoperative prediction of lymph node metastasis of gastric cancer.
    Feng R; Lu S; Sah BK; Beeharry MK; Zhang H; Yan M; Liu B; Li C; Zhu Z
    Cancer Biomark; 2018; 22(4):773-780. PubMed ID: 29843221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased miR-198 expression and its prognostic significance in human gastric cancer.
    Cui Z; Zheng X; Kong D
    World J Surg Oncol; 2016 Feb; 14():33. PubMed ID: 26852230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced miR-485-5p expression predicts poor prognosis in patients with gastric cancer.
    Jing LL; Mo XM
    Eur Rev Med Pharmacol Sci; 2016 Apr; 20(8):1516-20. PubMed ID: 27160123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating microRNA-196a/b are novel biomarkers associated with metastatic gastric cancer.
    Tsai MM; Wang CS; Tsai CY; Huang CG; Lee KF; Huang HW; Lin YH; Chi HC; Kuo LM; Lu PH; Lin KH
    Eur J Cancer; 2016 Sep; 64():137-48. PubMed ID: 27420607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological and prognostic significance of miR-4317 expression in gastric cancer patients.
    Zhang J; Tian ZL; Zhang WT; Cheng LM; Liu J; Cao YX; Zhang ZR
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2803-2808. PubMed ID: 31002131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of miR-141 downregulation in gastric cancer.
    Lu YB; Hu JJ; Sun WJ; Duan XH; Chen X
    Genet Mol Res; 2015 Dec; 14(4):17305-11. PubMed ID: 26681225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Down-regulation of miR-1236-3p is correlated with clinical progression and unfavorable prognosis in gastric cancer.
    Zhu XP; Wang XL; Ma J; Fang YF; Zhang HJ; Zhang C; Feng MC
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5914-5919. PubMed ID: 30280772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum miR-200c expression level as a prognostic biomarker for gastric cancer.
    Zhang HP; Sun FB; Li SJ
    Genet Mol Res; 2015 Dec; 14(4):15913-20. PubMed ID: 26662382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of miR-145-5p correlates with poor prognosis in gastric cancer.
    Zhang Y; Wen X; Hu XL; Cheng LZ; Yu JY; Wei ZB
    Eur Rev Med Pharmacol Sci; 2016 Jul; 20(14):3026-30. PubMed ID: 27460730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum level of microRNA-147 as diagnostic biomarker in human non-small cell lung cancer.
    Chu G; Zhang J; Chen X
    J Drug Target; 2016 Aug; 24(7):613-7. PubMed ID: 26581116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.